HRMDX
Price
$15.26
Change
+$0.04 (+0.26%)
Updated
Jul 31 closing price
Net Assets
497.22M
MVCAX
Price
$34.49
Change
-$0.11 (-0.32%)
Updated
Jul 31 closing price
Net Assets
17.38B
Interact to see
Advertisement

HRMDX vs MVCAX

HRMDX vs MVCAX Comparison Chart in %
View a ticker or compare two or three
VS
HRMDX vs. MVCAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRMDX is a Hold and MVCAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 17.4B vs. HRMDX (497M). MVCAX (1.09) and HRMDX (1.06) have matching dividends . HRMDX was incepted earlier than MVCAX: HRMDX (12 years) vs MVCAX (25 years). HRMDX (1.21) is less costly to investors than MVCAX (0.98). HRMDX is a more actively managed with annual turnover of: 72.00 vs. MVCAX (24.00). HRMDX (1000) and MVCAX (1000) have matching initial minimum investment requirements. HRMDX annual gain was more profitable for investors over the last year : 15.01 vs. MVCAX (11.71). MVCAX return over 5 years is better than : 17.90 vs. HRMDX (-0.42).
HRMDXMVCAXHRMDX / MVCAX
Total Expense Ratio1.100.97113%
Annual Report Gross Expense Ratio1.210.98123%
Fund Existence12 years25 years-
Gain YTD15.60614.699106%
Front LoadN/A6%-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets497M17.4B3%
Annual Yield % from dividends1.061.0997%
Returns for 1 year15.0111.71128%
Returns for 3 years11.6419.9658%
Returns for 5 years-0.4217.90-2%
Returns for 10 years62.7185.4673%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HKPD0.440.03
+8.48%
Cellyan Biotechnology Co Ltd
MEOH55.550.35
+0.63%
Methanex Corp
IQV235.02-2.77
-1.16%
IQVIA Holdings
AMPH19.94-0.44
-2.16%
Amphastar Pharmaceuticals
TONX2.98-0.12
-3.87%
TON Strategy Company